Scotiabank Maintains Sector Outperform on Amgen, Raises Price Target to $450

أمجين

Amgen Inc.

AMGN

0.00

Scotiabank analyst Louise Chen maintains Amgen (NASDAQ: AMGN) with a Sector Outperform and raises the price target from $385 to $450.